To include your compound in the COVID-19 Resource Center, submit it here.

Gleevec: Phase III data

The open-label, Swedish Phase III SSG XVIII trial in 400 patients showed that adjuvant treatment with once-daily 400 mg oral

Read the full 204 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE